These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33988312)

  • 1. Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey.
    Tini G; Cappelli F; Biagini E; Musumeci B; Merlo M; Crotti L; Cameli M; Di Bella G; Cipriani A; Marzo F; Guerra F; Forleo C; Gagliardi C; Zampieri M; Carigi S; Vianello PF; Mandoli GE; Ciliberti G; Lichelli L; Mariani D; Porcari A; Russo D; Licordari R; Ponziani A; Porto I; Perfetto F; Autore C; Rapezzi C; Sinagra G; Canepa M
    ESC Heart Fail; 2021 Aug; 8(4):3369-3374. PubMed ID: 33988312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis.
    Aimo A; Vergaro G; Castiglione V; Rapezzi C; Emdin M
    Eur J Intern Med; 2020 Oct; 80():66-72. PubMed ID: 32475765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report.
    Imamura T; Izumida T; Hori M; Tanaka S; Kinugawa K
    J Int Med Res; 2022 Jul; 50(7):3000605221078484. PubMed ID: 35904051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization and tolerance of beta-blockers among patients with AL amyloidosis.
    Briasoulis A; Stamatelopoulos K; Petropoulos I; Patras R; Theodorakakou F; Gavriatopoulou M; Ntalianis A; Dimopoulos MA; Kastritis E
    Amyloid; 2022 Mar; 29(1):31-37. PubMed ID: 34549676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction.
    Harada D; Asanoi H; Noto T; Takagawa J
    J Cardiol; 2020 Oct; 76(4):325-334. PubMed ID: 32475652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
    Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
    Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
    Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
    Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
    Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
    Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing.
    Elshazly MB; Senn T; Wu Y; Lindsay B; Saliba W; Wazni O; Cho L
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker target dosing and tolerability in a dedicated heart failure clinic in Johannesburg.
    Bolon J; McCutcheon K; Klug E; Smith D; Manga P
    Cardiovasc J Afr; 2019 Mar/Apr 23; 30(2):103-107. PubMed ID: 30740613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study.
    Bruggmann C; Fournier S; Panchaud A; Muller O; Sadeghipour F; Voirol P
    Swiss Med Wkly; 2020 Aug; 150():w20321. PubMed ID: 32835383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-blockade on mortality in patients with cardiac amyloidosis: A systematic review and meta-analysis.
    Kwok CS; Choy CH; Pinney J; Townend JN; Whelan C; Fontana M; Gillmore JD; Steeds RP; Moody WE
    ESC Heart Fail; 2024 Jul; ():. PubMed ID: 39041492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Paolillo S; Mapelli M; Bonomi A; Corrà U; Piepoli M; Veglia F; Salvioni E; Gentile P; Lagioia R; Metra M; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Carubelli V; Scrutino D; Badagliacca R; Raimondo R; Emdin M; Magrì D; Correale M; Parati G; Caravita S; Spadafora E; Re F; Cicoira M; Frigerio M; Bussotti M; Minà C; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Di Lenarda A; Passino C; Sciomer S; Iorio A; Zambon E; Guazzi M; Pacileo G; Ricci R; Contini M; Apostolo A; Palermo P; Clemenza F; Marchese G; Binno S; Lombardi C; Passantino A; Perrone Filardi P; Agostoni P
    Eur J Heart Fail; 2017 Jul; 19(7):904-914. PubMed ID: 28233458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of echocardiography to the diagnosis of patients with chronic heart failure].
    Pinamonti B
    Ital Heart J Suppl; 2000 Oct; 1(10):1311-6. PubMed ID: 11068713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.